112 related articles for article (PubMed ID: 1251645)
1. [Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide].
Kochnowski G; Rozek G; Wisńiewski J
Wiad Lek; 1976 Feb; 29(4):270-1. PubMed ID: 1251645
[No Abstract] [Full Text] [Related]
2. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
Seccia A; Scafuri L; Scognamillo A; Cocco G
G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355
[No Abstract] [Full Text] [Related]
3. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L
Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372
[No Abstract] [Full Text] [Related]
4. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
Athanassiades P; Lagoudis M; Kostis E
J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
[No Abstract] [Full Text] [Related]
5. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
[TBL] [Abstract][Full Text] [Related]
6. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
Castberg T; Kruse-Blinkenberg HO
Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973
[No Abstract] [Full Text] [Related]
7. Cytoxan therapy in the treatment of carcinoma of the lung. (Report of a five-year survival).
Castro L
W V Med J; 1974 Jun; 70(6):131-5. PubMed ID: 4524737
[No Abstract] [Full Text] [Related]
8. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
[No Abstract] [Full Text] [Related]
9. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
[No Abstract] [Full Text] [Related]
10. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
Host H
Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
[No Abstract] [Full Text] [Related]
11. [Polychemotherapy of bronchial carcinoma].
Fazio M; Minetto E; Cavallero P; Sartoris S
Minerva Med; 1970 Jun; 61(46):2567-70. PubMed ID: 5425737
[No Abstract] [Full Text] [Related]
12. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
[No Abstract] [Full Text] [Related]
13. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
Gandola L; Pozzi E; Tansini G
G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
[No Abstract] [Full Text] [Related]
14. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
Karrer K; Pridun N; Zwintz E
Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
[No Abstract] [Full Text] [Related]
15. Acute ECG changes during cyclophosphamide infusion in a patient with bronchogenic carcinoma.
Shachor J; Beker B; Geffen Y; Bruderman I
Cancer Treat Rep; 1985 Jun; 69(6):734-5. PubMed ID: 4016782
[No Abstract] [Full Text] [Related]
16. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
Bonomi P; O'Reilly W; Vogl SE; Ruckdeschel JC; Stolbach L; Bunting N; Creech RH
Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
